With its twice-yearly dosing, the siRNA-based drug might lead to better compliance with treatment. Still, cost is an issue.

A new commentary published in Annals of Internal Medicine from Roy Gulick, MD, Chief, Division of Infectious Diseases and ...

Medically reviewed by Anju Goel, MD Gonorrhea is treated with antibiotics. The recommended antibiotic for uncomplicated ...